|
À̳뿡ÀÌÄ¡¾ËÄÁ¼³Æà |
[±¹³»À¯¸íÁ¦¾àȸ»ç] CPL(Clinical Project Leader) ä¿ë
¼¿ï ÀüÁö¿ª | ´ëÇÐ(2~3³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
5³â¡è |
ä¿ë½Ã |
06.15 |
|
|
Áö¸à½º(ÁÖ) |
Áö¸à½º¢ß ¸ÞµðÄ®ÃÊÀ½ÆÄ»ç¾÷ºÎ Software Engineer ¸ðÁý
°æ±â ¼º³²½Ã ºÐ´ç±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
3³â¡è |
»ó½Ãä¿ë |
04.14 |
|
|
½ÌÅ©ÅÊÅ©(ÁÖ) |
¿Ü±¹°èÁ¦¾àȸ»ç CRA°æ·ÂÀÚ Ã¤¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
02.16 |
|
|
¿¡À̽ºÆÄÆ®³Ê½º |
±¹³» Á¦¾àȸ»ç CRM
¼¿ï ÀüÁö¿ª | ´ëÇÐ(2~3³â) Á¹¾÷ |
|
5³â¡è |
ä¿ë½Ã |
02.18 |
|
|
È޸չ븮 |
ÀÓ»ó ½ºÆä¼È¸®½ºÆ®
¼¿ï ¼ÛÆı¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
°æ·Â¹«°ü |
ä¿ë½Ã |
03.03 |
|
|
Áö¸à½º(ÁÖ) |
Áö¸à½º¢ß Áø´Ü»ç¾÷ºÎ ÅͳÎÀÚµ¿Á¦¾î½Ã½ºÅÛ ¼³°è ´ã´çÀÚ ¸ðÁý
°æ±â ¼º³²½Ã ºÐ´ç±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
2³â¡è |
»ó½Ãä¿ë |
04.14 |
|
|
(ÁÖ)ÇÁ·Î¸ÅÄ¡ÄÚ¸®¾Æ |
Á¦¾à»ç Çмú°³¹ßÆÀ °æ·ÂÀÚ(¿µ¾î°¡´ÉÀÚ)
¼¿ï ÀüÁö¿ª | ´ëÇÐ(2~3³â) Á¹¾÷ |
¶óÀ̼¾½ºIn/Out |
2³â¡è |
ä¿ë½Ã |
10.10 |
|
|
(ÁÖ)µå¸²¼Ö·ç¼Ç |
»óÀå ÀÇ·á±â±â ±â¾÷¿¬±¸¼Ò SW,HW,±â±¸°³¹ß °æ·ÂÁ÷ Ãæ¿ø
¼¿ï ÀüÁö¿ª | ´ëÇÐ(2~3³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
°æ·Â¹«°ü |
ä¿ë½Ã |
02.20 |
|
|
ICON Clinical Research Korea |
Jr. Clinical Research Associate(Oncology)
¼¿ï °³²±¸ | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
04.22 |
|
|
À̳뿡ÀÌÄ¡¾ËÄÁ¼³Æà |
[±¹³»À¯¸íÁ¦¾àȸ»ç] CRM(Clinical Research Manager) ä¿ë
¼¿ï ÀüÁö¿ª | ´ëÇÐ(2~3³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
5³â¡è |
ä¿ë½Ã |
06.15 |
|
|
¿¡À̽ºÆÄÆ®³Ê½º |
±¹³» ´ëÇü CRO CRA,CRM
¼¿ï ÀüÁö¿ª | ´ëÇÐ(2~3³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
02.18 |
|
|
Áö¸à½º(ÁÖ) |
Áö¸à½º¢ß ¸ÞµðÄ®ÃÊÀ½ÆÄ»ç¾÷ºÎ AOP Engineer ¸ðÁý
°æ±â ¼º³²½Ã ºÐ´ç±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
3³â¡è |
»ó½Ãä¿ë |
04.14 |
|
|
¸Å¹ö¸¯ÄÁ¼³Æà |
RA Specialist(»ç¿ø´ë¸®±Þ)-¿Ü±¹°è Á¦¾à
¼¿ï ÀüÁö¿ª | ´ëÇÐ(2~3³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
2³â¡è |
ä¿ë½Ã |
12.05 |
|
|
M&C |
·¯½Ã¾Æ Å뿪 ¹× ¹ø¿ª
¼¿ï °³²±¸ | Çз¹«°ü |
¹«¿ª/ÇØ¿Ü¿µ¾÷/Åë¹ø¿ª |
°æ·Â¹«°ü |
ä¿ë½Ã |
10.06 |
|
|
ICON Clinical Research Korea |
Study Start-up Associate
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
04.22 |
|